A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Trichlormethiazide
Bupranolol
Oxyphenbutazone may decrease the antihypertensive activities of Bupranolol.
Trichlormethiazide
Bopindolol
Oxyphenbutazone may decrease the antihypertensive activities of Bopindolol.
Trichlormethiazide
Bufuralol
Oxyphenbutazone may decrease the antihypertensive activities of Bufuralol.
Trichlormethiazide
Nebivolol
Oxyphenbutazone may decrease the antihypertensive activities of Nebivolol.
Trichlormethiazide
Celiprolol
Oxyphenbutazone may decrease the antihypertensive activities of Celiprolol.
Trichlormethiazide
Dexpropranolol
Oxyphenbutazone may decrease the antihypertensive activities of Dexpropranolol.
Trichlormethiazide
Penbutolol
Oxyphenbutazone may decrease the antihypertensive activities of Penbutolol.
Trichlormethiazide
Practolol
Oxyphenbutazone may decrease the antihypertensive activities of Practolol.
Trichlormethiazide
Bevantolol
Oxyphenbutazone may decrease the antihypertensive activities of Bevantolol.
Trichlormethiazide
Cilazaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Cilazaprilat.
Trichlormethiazide
Quinoline Yellow WS
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Quinoline Yellow WS.
Trichlormethiazide
Quinaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Quinaprilat.
Trichlormethiazide
Perindoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Perindoprilat.
Trichlormethiazide
Moexiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Moexiprilat.
Trichlormethiazide
Trandolaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Trandolaprilat.
Trichlormethiazide
Ramiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Ramiprilat.
Trichlormethiazide
Fosinoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Fosinoprilat.
Trichlormethiazide
Benazeprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Benazeprilat.
Trichlormethiazide
Delapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Delapril.
Trichlormethiazide
Zofenopril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Zofenopril.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3